Concepedia

David Gómez-Peregrina

DG

3

Publications

62

Citations

3

H-Index

2021

Active since

Affiliations

Vall d'Hebron Institute of Oncology(Current)

Dana-Farber Cancer Institute

Vall d'Hebron Hospital Universitari

Universitat de Barcelona

David Gómez-Peregrina is an author at Vall d'Hebron Institute of Oncology specializing in oncology, cancer research, and medicine.

ORCID

Top concepts

Publications per year

2021–2023

3

Publications

3

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

César Serrano, Sebastian Bauer, David Gómez-Peregrina et al. · Annals of Oncology · 2023 · 38 citations · Full text

, , +9

E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor

Alfonso García‐Valverde, Jordi Rosell, Sergi Sayols et al. · Oncogene · 2021 · 14 citations

, , +8

The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth

Elizabeth Proaño-Pérez, Eva Serrano‐Candelas, Alfonso García‐Valverde et al. · Cancer Gene Therapy · 2022 · 10 citations

Rows per page

1–3 of 3